Showing results (11-20 of 216) with videos related to
Sort By:
Pageof 22
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|May 2, 2025
Unlocking therapeutic synergy: IDH inhibitors and immunotherapy combination in preclinical and clinical IDH mutant glioma models - A systematic reviewManjeera Ramadas, Nikhitha Jacob, Malaka Ameratunga, et al.BMJ Case Reports|December 31, 2015
Hypopharyngeal large cell neuroendocrine carcinomaWei-I Lee, Malaka Ameratunga, Justin du Plessis, et al.Asia-Pacific Journal of Clinical Oncology|August 20, 2014
Epidermal growth factor receptor-tyrosine kinase inhibitors in advanced squamous cell carcinoma of the lung: a meta-analysisMalaka Ameratunga, Nick Pavlakis, Val Gebski, et al.Oncotarget|June 2, 2018
CNS cancer immunity cycle and strategies to target this for glioblastomaMalaka Ameratunga, Niamh Coleman, Liam Welsh, et al.Journal of Immunotherapy and Precision Oncology|February 8, 2024
Sustained Clinical Response to Immunotherapy Followed by BET Inhibitor in a Patient with Unresectable Sinonasal NUT CarcinomaHarriet Herbison, Sidney Davis, David Nickless, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2018
To Cycle or Fight-CDK4/6 Inhibitors at the Crossroads of Anticancer ImmunityMalaka Ameratunga, Emma Kipps, Alicia F C Okines, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|September 2, 2024
Herpes zoster in patients with glioma treated with temozolomideAlison Hiong, Adam H Lapidus, Lucy Gately, et al.The Cochrane Database of Systematic Reviews|November 28, 2018
Anti-angiogenic therapy for high-grade gliomaMalaka Ameratunga, Nick Pavlakis, Helen Wheeler, et al.Seminars in Cancer Biology|May 4, 2010
Normal stem cells and cancer stem cells: similar and differentMark ShackletonThe Journal of Investigative Dermatology|March 17, 2011
Pulling RANK: are some melanoma cells more malignant than others?Mark ShackletonPageof 22